Skip to content
★ Sign in to follow
시너

시너지이노베이션 Stock: price and insider trades · South Korea

KR·Mcap ₩122.6BHealth Care

No insider purchase over the last 90 days. The latest, by 시너지파트너스, was filed 05 Dec 2022.

시너지이노베이션: what insiders have been doing

Every trade that managers of 시너지이노베이션 disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. Over the twelve months to 8 November 2026, 1 filing were filed, from 1 insider.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

With 1 filing in twelve months, the company is quieter than the median of 7 filings across the 2,657 companies we follow on the same exchange. The full history, which starts in 2021, counts 3 purchases against 36 sales.

Insider buying of 시너지이노베이션 has been absent for the past year.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.

Insider Decl.
45
Thresholds
n/a
Buy Volume
€7M
3 ops. · all time
Sell Volume
€10M
36 ops. · all time

Since the insiders bought

  • Filed 05 Dec 2022 · 1436 days ago · €529k
    -11.1%
    Entry ₩3,115 · Close at T+365 ₩2,770

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 8,840 of 26,911 companies
60.1
score / 100
Value
66
Quality
54
FCF yld6.4%
Earn yld2.5%
EV/EBITDA6.1x
ROE6.8%
Gross mgn45%
Net mgn2.7%
Debt/EBITDA1.4x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩1,391
Analyst consensus
·
Income statement
Revenue₩113.1B
Gross profit₩50.3B45% margin
EBITDA₩26B23% margin
Net income₩3B8.6% margin
Valuation
Beta0.15
Balance sheet & cash
Market cap₩122.6B
Total debt₩35.9B
Free Cash Flow₩7.8B
Debt / Equity11%
Profitability & ownership
ROE6.8%
ROA3.5%
% insiders38.3%
% institutions0.5%
Last declaration on 21 May 2026
Declarations45 total
  • ●
    Executives
    Executives
    0DART
  • ●
    Related company / holdingExecutives
    0DART
    0KRXDART:20241125000263
  • ▼
    Related company / holdingExecutives
    €183kest.0DART
    100,000 sharesKRXDART:20240823000380
  • ▼
    Related company / holdingExecutives
    €1.0Mest.0DART
    488,454 sharesKRXDART:20240405002908
  • ▼
    Related company / holdingExecutives
    €189kest.0DART
    100,000 sharesKRXDART:20231228000754
  • ▼
    Related company / holdingExecutives
    €193kest.0DART
    100,000 sharesKRXDART:20231128000832
  • ▼
    Related company / holdingExecutives
    €164kest.0DART
    100,000 sharesKRXDART:20230518000051
  • ▼
    Related company / holdingExecutives
    €206kest.0DART
    100,000 sharesKRXDART:20230504000686
  • ▼
    Related company / holdingExecutives(filed)
    €212kest.0DART
    100,000 sharesKRXDART:20230403004166
  • ▼
    Related company / holdingExecutives(filed)
    €226kest.0DART
    100,000 sharesKRXDART:20221219000244
  • ▲
    Related company / holdingExecutives
    734M KRW3DART
    215,000 shares@ ₩3,415.007.3% of flowShareKRXDART:20221205000370
    Canonical exit: 27 Feb 2023 (T+90)
  • ▼
    Executives
    734M KRW10DART
    215,000 shares@ ₩3,415.00100.0% of flowShareKRXDART:20221205000363
  • ▼
    Related company / holdingExecutives(filed)
    €232kest.0DART
    100,000 sharesKRXDART:20221121000248
  • ▼
    Related company / holdingExecutives(filed)
    €231kest.0DART
    100,000 sharesKRXDART:20221104000454
  • ●
    Executives
    Executives(filed)
    0DART
  • ▼
    Related company / holdingExecutives(filed)
    €223kest.0DART
    100,000 sharesKRXDART:20220930000689
  • ▼
    Related company / holdingExecutives(filed)
    €282kest.0DART
    100,000 sharesKRXDART:20220823000278
  • ▲
    Related company / holdingExecutives
    2B KRW4DART
    1,108,362 shares@ ₩2,021.0023.4% of flowShareKRXDART:20220805000514
    Canonical exit: 1 Nov 2022 (T+90)
  • ▼
    Related company / holdingExecutives(filed)
    €310kest.0DART
    100,000 sharesKRXDART:20220805000498
  • ▼
    Related company / holdingExecutives(filed)
    €291kest.0DART
    100,000 sharesKRXDART:20220713000327
  • ▲
    Related company / holdingExecutives
    7B KRW9DART
    1,787,713 shares@ ₩3,810.0069.3% of flowShareKRXDART:20220630000948
    Canonical exit: 25 Sept 2022 (T+90)
  • ▼
    Related company / holdingExecutives(filed)
    €271kest.0DART
    100,000 sharesKRXDART:20220630000928
  • ▼
    Related company / holdingExecutives(filed)
    €292kest.0DART
    100,000 sharesKRXDART:20220520000543
  • ▼
    Related company / holdingExecutives(filed)
    €293kest.0DART
    100,000 sharesKRXDART:20220511000745
  • ▼
    Related company / holdingExecutives(filed)
    €317kest.0DART
    100,000 sharesKRXDART:20220413002531

25 of 45 declarations

About 시너지이노베이션

시너지이노베이션 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on innovation and the development of pharmaceutical solutions.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations